CMU CARNIVAL BOOTH
construction project lead - 2014 - Carnegie Mellon University
CMU CARNIVAL BOOTH
construction project lead - 2014 - Carnegie Mellon University
SPINAL IMPLANT
graduate product manager - 2019 - 2020 - printerprezz
SPINAL IMPLANT
graduate product manager - 2019 - 2020 - printerprezz
CLINICAL RESEARCH
clinical research coordinator - 2016 - 2019 - Dana Farber Cancer Institute
CLINICAL RESEARCH
clinical research coordinator - 2016 - 2019 - Dana Farber Cancer Institute
Stress Relief App
Product Designer
Interface Aesthetics Graduate Course UC Berkeley School of Information
Project Duration: 3 months (Spring 2020)
![resarch.PNG](https://static.wixstatic.com/media/c0f8ee_78055cd6eb764cf48da74ef8e40ae126~mv2.png/v1/fill/w_542,h_414,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/resarch_PNG.png)
​
Paper on testing the feasibility and safety of omitting routine growth factors during adjuvant breast cancer chemotherapy to avoid unnecessary toxicity and expense (April 2020).
​
​
​
​
![c_edited.jpg](https://static.wixstatic.com/media/c0f8ee_2ebe3195eda243b5b4d9fca1dba04125~mv2.jpg/v1/fill/w_523,h_371,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/c_edited.jpg)
Abstract for a phase II study evaluating the efficacy of GDC-0084 in combination with trastuzumab for the treatment of CNS metastases in patients with HER2-positive breast cancer (August 2019 & February 2020)
​
​
​
![ASCO Poster 2018](https://static.wixstatic.com/media/c0f8ee_32d5ff6d2052439ab21bb49228d7a522~mv2.png/v1/fill/w_548,h_276,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/poster_PNG.png)
​​
​
Poster titled "Avoiding peg-filgrastim (Peg-F) prophylaxis during paclitaxel (T) portion of the dosedense (DD) doxorubicin-cyclophosphamide (AC) regimen: a prospective study" presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL (June 2018).
​
​
![SABCS 2019 Poster](https://static.wixstatic.com/media/c0f8ee_2c9627275cb74b89a867141b8b7624db~mv2.jpg/v1/fill/w_542,h_271,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/SABCS%202019%20Poster.jpg)
Poster titled "Phase II Trial of GDC-0084 in combination with Trastuzumab for Patients with HER2-Positive Breast Cancer Brain Metastases (BCBM)" presented at the San Antonio Breast Cancer Symposium (SABCS) Annual Meeting in San Antonio, TX (December 2019).
Other conferences attended:
​
-
BIOMEDevice
San Jose, CA | December 2020​
​
-
Center for Effective Global Action: Innovations in Health Data & Measurement
San Francisco, CA | October 2020
​
-
San Antonio Breast Cancer Symposium
San Antonio, TX | December 2018
​
-
Oncology Live State of the Science Summit in Breast Oncology
Boston, MA | May 2018
​
-
Roche BETi NP39487 Clinical Trial Investigator Meeting
New York, NY & Toronto, Ontario | October 2017 & 2018
​
-
Translational Breast Cancer Research Consortium Annual Meeting
Nashville, TN | September 2017
![IMG_3585.JPG](https://static.wixstatic.com/media/c0f8ee_89cad3607ce4481a94ca1f007040bdad~mv2.jpg/v1/fill/w_333,h_444,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_3585_JPG.jpg)
![cgph.jpg](https://static.wixstatic.com/media/c0f8ee_9bc7cbf3ab3f43d7b4781d20d7dff2b9~mv2.jpg/v1/crop/x_0,y_13,w_225,h_172/fill/w_166,h_127,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/cgph.jpg)
As part of the UC Berkeley Global Health Specialty Program, I wrote two relevant policy brief proposals focused on women's health issues. These articles call to action the clinical needs of preventing postpartum hemorrhage in Chad and improving diagnostic systems for breast cancer in Argentina. Data surrounding the issue and rationale for geographic selection are discussed, followed by potential solutions and tangible recommendations for intervention.